Eris Lifesciences Limited has informed the Exchange about Schedule of meet
ERIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Eris Lifesciences Limited has informed exchanges about a scheduled investor meeting with Franklin Templeton on May 29, 2026 at 10:30 AM IST. The meeting will be held virtually in a one-on-one format with Mr. Krishnakumar Vaidyanathan representing the company's management. The company clarified that discussions will only reference publicly available documents and no Unpublished Price Sensitive Information (UPSI) will be shared. This disclosure is made under SEBI's Regulation 30 as part of routine regulatory compliance.
This is a standard investor relations activity with no material impact on the stock. The company's disclosure of a Franklin Templeton meeting indicates ongoing engagement with institutional investors, though no price-sensitive information will be exchanged.